Blue Square Asset Management LLC Takes $2.20 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Blue Square Asset Management LLC acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 16,038 shares of the financial services provider’s stock, valued at approximately $2,201,000. iShares Biotechnology ETF makes up approximately 1.5% of Blue Square Asset Management LLC’s holdings, making the stock its 21st biggest position.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Future Financial Wealth Managment LLC bought a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $27,000. Pacifica Partners Inc. grew its holdings in iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 130 shares during the last quarter. Crewe Advisors LLC grew its holdings in iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 78 shares during the last quarter. YHB Investment Advisors Inc. bought a new stake in iShares Biotechnology ETF in the 1st quarter worth $37,000. Finally, Northwest Financial Advisors bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $42,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 2.4 %

Shares of IBB traded up $3.32 during trading hours on Thursday, reaching $143.85. 2,659,277 shares of the company traded hands, compared to its average volume of 1,626,885. The company’s fifty day moving average price is $135.97 and its two-hundred day moving average price is $135.19. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $144.44.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.